RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
FRA:RHK - Deutsche Boerse Ag - DE0007042301 - Common Stock - Currency: EUR
Taking everything into account, RHK scores 5 out of 10 in our fundamental rating. RHK was compared to 25 industry peers in the Health Care Providers & Services industry. RHK has an excellent financial health rating, but there are some minor concerns on its profitability. RHK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RHK had positive earnings in the past year.
RHK had a positive operating cash flow in the past year.
RHK had positive earnings in each of the past 5 years.
RHK had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
RHK has a Return On Assets of 2.34%. This is comparable to the rest of the industry: RHK outperforms 52.00% of its industry peers.
RHK has a Return On Equity of 3.35%. This is in the lower half of the industry: RHK underperforms 64.00% of its industry peers.
RHK's Return On Invested Capital of 2.75% is on the low side compared to the rest of the industry. RHK is outperformed by 64.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RHK is below the industry average of 6.33%.
The last Return On Invested Capital (2.75%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.35% | ||
| ROIC | 2.75% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
With a Profit Margin value of 2.72%, RHK perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
In the last couple of years the Profit Margin of RHK has declined.
Looking at the Operating Margin, with a value of 3.04%, RHK is doing worse than 64.00% of the companies in the same industry.
RHK's Operating Margin has declined in the last couple of years.
RHK has a better Gross Margin (66.44%) than 68.00% of its industry peers.
In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.04% | ||
| PM (TTM) | 2.72% | ||
| GM | 66.44% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RHK is destroying value.
Compared to 1 year ago, RHK has about the same amount of shares outstanding.
The number of shares outstanding for RHK remains at a similar level compared to 5 years ago.
Compared to 1 year ago, RHK has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.04 indicates that RHK is not in any danger for bankruptcy at the moment.
The Altman-Z score of RHK (3.04) is better than 92.00% of its industry peers.
RHK has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as RHK would need 2.62 years to pay back of all of its debts.
RHK has a Debt to FCF ratio of 2.62. This is amongst the best in the industry. RHK outperforms 92.00% of its industry peers.
RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
RHK has a better Debt to Equity ratio (0.09) than 96.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 2.62 | ||
| Altman-Z | 3.04 |
ROIC/WACC0.43
WACC6.35%
2.3 Liquidity
RHK has a Current Ratio of 2.23. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.23, RHK belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
RHK has a Quick Ratio of 2.14. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
RHK has a Quick ratio of 2.14. This is amongst the best in the industry. RHK outperforms 92.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
The earnings per share for RHK have decreased by -7.07% in the last year.
RHK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.03% yearly.
Looking at the last year, RHK shows a quite strong growth in Revenue. The Revenue has grown by 9.58% in the last year.
Measured over the past years, RHK shows a small growth in Revenue. The Revenue has been growing by 4.12% on average per year.
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%
3.2 Future
RHK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.28% yearly.
The Revenue is expected to grow by 5.94% on average over the next years.
EPS Next Y11.29%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
EPS Next 5Y12.28%
Revenue Next Year8.14%
Revenue Next 2Y6.08%
Revenue Next 3Y5.77%
Revenue Next 5Y5.94%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.33, the valuation of RHK can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of RHK indicates a slightly more expensive valuation: RHK is more expensive than 64.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.35, RHK is valued at the same level.
RHK is valuated correctly with a Price/Forward Earnings ratio of 16.68.
RHK's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.20. RHK is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.33 | ||
| Fwd PE | 16.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RHK indicates a rather cheap valuation: RHK is cheaper than 100.00% of the companies listed in the same industry.
RHK's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.98 | ||
| EV/EBITDA | 0.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.89
PEG (5Y)627.34
EPS Next 2Y10.72%
EPS Next 3Y10.65%
5. Dividend
5.1 Amount
RHK has a yearly dividend return of 0.78%, which is pretty low.
Compared to an average industry Dividend Yield of 2.77, RHK has a dividend in line with its industry peers.
With a Dividend Yield of 0.78, RHK pays less dividend than the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
FRA:RHK (5/26/2025, 7:00:00 PM)
12.8
-0.1 (-0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap857.09M
Analysts45.71
Price Target14.28 (11.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.33 | ||
| Fwd PE | 16.68 | ||
| P/S | 0.54 | ||
| P/FCF | 14.98 | ||
| P/OCF | 6.72 | ||
| P/B | 0.66 | ||
| P/tB | 0.76 | ||
| EV/EBITDA | 0.52 |
EPS(TTM)0.6
EY4.69%
EPS(NY)0.77
Fwd EY6%
FCF(TTM)0.85
FCFY6.67%
OCF(TTM)1.91
OCFY14.89%
SpS23.83
BVpS19.35
TBVpS16.76
PEG (NY)1.89
PEG (5Y)627.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.35% | ||
| ROCE | 3.34% | ||
| ROIC | 2.75% | ||
| ROICexc | 4.77% | ||
| ROICexgc | 6.01% | ||
| OM | 3.04% | ||
| PM (TTM) | 2.72% | ||
| GM | 66.44% | ||
| FCFM | 3.58% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
ROICexc(3y)3.1%
ROICexc(5y)2.62%
ROICexgc(3y)3.7%
ROICexgc(5y)3.13%
ROCE(3y)2.85%
ROCE(5y)2.44%
ROICexcg growth 3Y17.7%
ROICexcg growth 5Y-1.56%
ROICexc growth 3Y17.75%
ROICexc growth 5Y-1.75%
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 2.62 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 112.46% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 15.15 | ||
| Cash Conversion | 114.87% | ||
| Profit Quality | 131.95% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 3.04 |
F-Score6
WACC6.35%
ROIC/WACC0.43
Cap/Depr(3y)97.27%
Cap/Depr(5y)108.32%
Cap/Sales(3y)4.24%
Cap/Sales(5y)5.08%
Profit Quality(3y)86.55%
Profit Quality(5y)290.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
EPS Next Y11.29%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
EPS Next 5Y12.28%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%
Revenue Next Year8.14%
Revenue Next 2Y6.08%
Revenue Next 3Y5.77%
Revenue Next 5Y5.94%
EBIT growth 1Y18.95%
EBIT growth 3Y16.29%
EBIT growth 5Y-3.2%
EBIT Next Year145.13%
EBIT Next 3Y44.3%
EBIT Next 5Y34.88%
FCF growth 1Y23.81%
FCF growth 3Y42.66%
FCF growth 5YN/A
OCF growth 1Y17.06%
OCF growth 3Y9.38%
OCF growth 5Y21.95%